On 2025-05-08, 4D Molecular Therapeutics, Inc. (FDMT) announced earnings per share of $-0.86 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.84.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.87 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.84 | $-0.86 |
| 2025-02-28 | 2024-12-31 | $-0.80 | $-0.90 |
| 2024-11-13 | 2024-09-30 | $-0.67 | $-0.79 |
| 2024-08-08 | 2024-06-30 | $-0.72 | $-0.63 |
| 2024-05-09 | 2024-03-31 | $-0.73 | $-0.66 |
| 2024-02-29 | 2023-12-31 | $-0.68 | $-0.77 |
| 2023-11-09 | 2023-09-30 | $-0.67 | $-0.24 |
| 2023-08-09 | 2023-06-30 | $-0.77 | $-0.77 |
| 2023-05-10 | 2023-03-31 | $-0.88 | $-0.88 |
| 2023-03-15 | 2022-12-31 | $-0.75 | $-0.84 |
| 2022-11-08 | 2022-09-30 | $-0.85 | $-0.79 |
| 2022-08-11 | 2022-06-30 | $-0.78 | $-0.87 |
| 2022-05-12 | 2022-03-31 | $-0.73 | $-0.82 |
| 2022-03-28 | 2021-12-31 | $-0.82 | $-0.85 |
| 2021-11-10 | 2021-09-30 | $-0.83 | $-0.82 |
| 2021-08-12 | 2021-06-30 | $-0.71 | $-0.28 |
| 2021-05-13 | 2021-03-31 | -- | $-0.61 |